tetano
Editor, Senior Moderator
Pathog Dis
. 2020 Jun 13;ftaa026.
doi: 10.1093/femspd/ftaa026. Online ahead of print.
The Pathologic Autopsy of Coronavirus Disease 2019 (COVID-2019) in China: A Review
Baoyong Zhou[SUP] 1 [/SUP], Wei Zhao[SUP] 2 [/SUP], Ruixi Feng[SUP] 2 [/SUP], Xiaohui Zhang[SUP] 3 [/SUP], Xuemei Li[SUP] 4 [/SUP], Yang Zhou[SUP] 4 [/SUP], Li Peng[SUP] 4 [/SUP], Yixin Li[SUP] 4 [/SUP], Jinyan Zhang[SUP] 4 [/SUP], Jing Luo[SUP] 4 [/SUP], Lingyu Li[SUP] 4 [/SUP], Jingxian Wu[SUP] 4 [/SUP], Changhong Yang[SUP] 2 [/SUP], Meijiao Wang[SUP] 2 [/SUP], Yong Zhao[SUP] 4 [/SUP], Kejian Wang[SUP] 2 [/SUP], Huarong Yu[SUP] 2 [/SUP], Qiling Peng[SUP] 2 [/SUP], Ning Jiang[SUP] 4 [/SUP]
Affiliations
Abstract
The coronavirus disease 2019 (COVID-2019) emerged in Wuhan, China, has rapidly spread to many countries across all six WHO regions. However, its pathobiology remains incompletely understood and many efforts are underway to study it worldwide. To clarify its pathogenesis to some extent, it will inevitably require lots of COVID-2019-associated deaths at pathologic autopsy. Pathologists from all over the world have raised concern with pathologic autopsy relating to COVID-2019. The issue of whether a person dies from COVID-2019 infection or not always is an ambiguous problem in some cases, and ongoing epidemiology from China may shed light on it. This review retrospectively summarizes the research status of pathologic autopsy in COVID-2019 in China, which will be important for the cause of death, prevention, control and clinical strategies of COVID-2019. Moreover, it points out several challenges at autopsy. We believe pathological studies from China enable to correlate clinical symptoms and pathological features of COVID-2019 for doctors and provide an insight into COVID-2019 disease.
Keywords: COVID-2019; Infectious disease; Pathologic autopsy; Pneumonia.
. 2020 Jun 13;ftaa026.
doi: 10.1093/femspd/ftaa026. Online ahead of print.
The Pathologic Autopsy of Coronavirus Disease 2019 (COVID-2019) in China: A Review
Baoyong Zhou[SUP] 1 [/SUP], Wei Zhao[SUP] 2 [/SUP], Ruixi Feng[SUP] 2 [/SUP], Xiaohui Zhang[SUP] 3 [/SUP], Xuemei Li[SUP] 4 [/SUP], Yang Zhou[SUP] 4 [/SUP], Li Peng[SUP] 4 [/SUP], Yixin Li[SUP] 4 [/SUP], Jinyan Zhang[SUP] 4 [/SUP], Jing Luo[SUP] 4 [/SUP], Lingyu Li[SUP] 4 [/SUP], Jingxian Wu[SUP] 4 [/SUP], Changhong Yang[SUP] 2 [/SUP], Meijiao Wang[SUP] 2 [/SUP], Yong Zhao[SUP] 4 [/SUP], Kejian Wang[SUP] 2 [/SUP], Huarong Yu[SUP] 2 [/SUP], Qiling Peng[SUP] 2 [/SUP], Ning Jiang[SUP] 4 [/SUP]
Affiliations
- PMID: 32533838
- DOI: 10.1093/femspd/ftaa026
Abstract
The coronavirus disease 2019 (COVID-2019) emerged in Wuhan, China, has rapidly spread to many countries across all six WHO regions. However, its pathobiology remains incompletely understood and many efforts are underway to study it worldwide. To clarify its pathogenesis to some extent, it will inevitably require lots of COVID-2019-associated deaths at pathologic autopsy. Pathologists from all over the world have raised concern with pathologic autopsy relating to COVID-2019. The issue of whether a person dies from COVID-2019 infection or not always is an ambiguous problem in some cases, and ongoing epidemiology from China may shed light on it. This review retrospectively summarizes the research status of pathologic autopsy in COVID-2019 in China, which will be important for the cause of death, prevention, control and clinical strategies of COVID-2019. Moreover, it points out several challenges at autopsy. We believe pathological studies from China enable to correlate clinical symptoms and pathological features of COVID-2019 for doctors and provide an insight into COVID-2019 disease.
Keywords: COVID-2019; Infectious disease; Pathologic autopsy; Pneumonia.